Corrigendum to “inhibition of PARP Prevents Angiotensin II-induced Aortic Fibrosis in Rats”. [int. J. Cardiol. (2013 Sep 1) 167(5) 2285–2293]

Y. Wang,L. Wang,F. Zhang,C. Zhang,S. Deng,R. Wang,Y. Zhang,D. Huang,K. Huang
DOI: https://doi.org/10.1016/j.ijcard.2015.05.153
IF: 4.039
2015-01-01
International Journal of Cardiology
Abstract:The authors regret that there was an error in Fig. 2A in this article. We used a wrong figure (the 4th Masson-staining figure) in Fig. 2A. Fig. 2A should be corrected as the figure below. The authors would like to apologize for any inconvenience caused. Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in ratsInternational Journal of CardiologyVol. 167Issue 5PreviewFibrosis is one of the major pathological features of hypertensive vascular disease. In this study, we aim to explore the possible protective effects of poly(ADP-ribose) polymerase (PARP) inhibitor on angiotensin II (AngII)-induced aortic fibrosis. Full-Text PDF
What problem does this paper attempt to address?